These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 34640510)
1. Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses. Vianello A; Guarnieri G; Braccioni F; Molena B; Lococo S; Achille A; Lionello F; Salviati L; Caminati M; Senna G J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640510 [TBL] [Abstract][Full Text] [Related]
2. Ethnic differences in alpha-1 antitrypsin deficiency allele frequencies may partially explain national differences in COVID-19 fatality rates. Shapira G; Shomron N; Gurwitz D FASEB J; 2020 Nov; 34(11):14160-14165. PubMed ID: 32960480 [TBL] [Abstract][Full Text] [Related]
3. Alpha1-antitrypsin deficiency: a clinical-genetic overview. Abboud RT; Nelson TN; Jung B; Mattman A Appl Clin Genet; 2011; 4():55-65. PubMed ID: 23776367 [TBL] [Abstract][Full Text] [Related]
4. Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study. Rodríguez Hermosa JL; Vargas Centanaro G; González Castro ME; Miravitlles M; Lázaro-Asegurado L; Jiménez-Rodríguez BM; Rodríguez RA; Moreno Méndez R; Torres-Duran M; Hernández-Pérez JM; Humanes-Navarro AM; Calle Rubio M Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831051 [TBL] [Abstract][Full Text] [Related]
5. COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale. Ferrarotti I; Ottaviani S; Balderacchi AM; Barzon V; De Silvestri A; Piloni D; Mariani F; Corsico AG Respir Med; 2021 Jul; 183():106440. PubMed ID: 33964815 [TBL] [Abstract][Full Text] [Related]
6. Introducing standards of the best medical practice for patients with inherited alpha-1-antitrypsin deficiency in Central Eastern Europe. Valiulis A; Utkus A; Stukas R; Valiulis A; Siderius L; Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):107-14. PubMed ID: 24798601 [TBL] [Abstract][Full Text] [Related]
7. Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic. Herth FJF; Sandhaus RA; Turner AM; Sucena M; Welte T; Greulich T Int J Chron Obstruct Pulmon Dis; 2021; 16():2983-2996. PubMed ID: 34754184 [TBL] [Abstract][Full Text] [Related]
9. Molecular diagnosis of alpha1-antitrypsin deficiency: A new method based on Luminex technology. Ottaviani S; Barzon V; Buxens A; Gorrini M; Larruskain A; El Hamss R; Balderacchi AM; Corsico AG; Ferrarotti I J Clin Lab Anal; 2020 Jul; 34(7):e23279. PubMed ID: 32181528 [TBL] [Abstract][Full Text] [Related]
10. Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients. Nygren D; Mölstad U; Thulesius H; Hillman M; Broman LM; Tanash H; Landin-Olsson M; Rasmussen M; Thunander M Int J Gen Med; 2022; 15():5843-5848. PubMed ID: 35789772 [TBL] [Abstract][Full Text] [Related]
11. Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of Seixas S; Marques PI Appl Clin Genet; 2021; 14():173-194. PubMed ID: 33790624 [TBL] [Abstract][Full Text] [Related]
12. Alpha1-antitrypsin deficiency: New therapies on the horizon. Remih K; Amzou S; Strnad P Curr Opin Pharmacol; 2021 Aug; 59():149-156. PubMed ID: 34256305 [TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence. Rahaghi FF; Miravitlles M Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837 [TBL] [Abstract][Full Text] [Related]
15. d-Galactose treatment increases ACE2, TMPRSS2, and FURIN and reduces SERPINA1 mRNA expression in A549 human lung epithelial cells. Baristaite G; Gurwitz D Drug Dev Res; 2022 May; 83(3):622-627. PubMed ID: 34677831 [TBL] [Abstract][Full Text] [Related]
16. Genetically engineered cell lines for α1-antitrypsin expression. Ji Q; Guo C; Xie C; Wu Y; Zhang P; Li H; Lu Y Biotechnol Lett; 2017 Oct; 39(10):1471-1476. PubMed ID: 28721587 [TBL] [Abstract][Full Text] [Related]
17. Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches. Viglio S; Bak EG; Schouten IGM; Iadarola P; Stolk J Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494436 [TBL] [Abstract][Full Text] [Related]
18. Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency. Kueppers F; Andrake MD; Xu Q; Dunbrack RL; Kim J; Sanders CL BMC Med Genet; 2019 Jul; 20(1):125. PubMed ID: 31307431 [TBL] [Abstract][Full Text] [Related]
19. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency. O'Brien ME; Fee L; Browne N; Carroll TP; Meleady P; Henry M; McQuillan K; Murphy MP; Logan M; McCarthy C; McElvaney OJ; Reeves EP; McElvaney NG Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730 [TBL] [Abstract][Full Text] [Related]
20. SERPINA1 long transcripts produce non-secretory alpha1-antitrypsin isoform: In vitro translation in living cells. Maslakova AA; Golyshev SA; Potashnikova DM; Moisenovich AM; Orlovsky IV; Smirnova OV; Rubtsov MA Int J Biol Macromol; 2023 Jun; 241():124433. PubMed ID: 37086761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]